SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 460.55 |
| Enterprise Value ($M) | 386.00 |
| Book Value ($M) | 134.16 |
| Book Value / Share | 1.40 |
| Price / Book | 3.43 |
| NCAV ($M) | 78.14 |
| NCAV / Share | 0.82 |
| Price / NCAV | 5.89 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.75 |
| Return on Assets (ROA) | -0.17 |
| Return on Equity (ROE) | -0.71 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.18 |
| Current Ratio | 3.18 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 565.81 |
| Assets | 621.83 |
| Liabilities | 487.67 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 97.06 |
| Operating Income | -151.74 |
| Net Income | -130.39 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -184.16 |
| Cash from Investing | 101.92 |
| Cash from Financing | 2.55 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 5.21 | -31.08 | |
| 13G | Morgan Stanley | 5.50 | ||
| 13G/A | Fmr Llc | 15.00 | 3.68 | |
| 13G/A | Polaris Venture Partners VI, L.P. | 11.50 | -8.11 | |
| 13G | Rosenthal Arnon | 5.83 | ||
| 13G/A | BlackRock Inc. | 9.60 | 9.50 | |
| 13G/A | FIL Ltd | 14.52 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 37,697 | 322,273 | 11.70 | |
| 57,964 | 346,215 | 16.74 | |
| 36,481 | 197,690 | 18.45 | |
| 163,001 | 199,923 | 81.53 | |
| 45,086 | 188,091 | 23.97 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ADPT – Adaptive Biotechnologies Corporation | AGIO – Agios Pharmaceuticals, Inc. |
| AKRO – Akero Therapeutics, Inc. | ALKS – Alkermes plc |
| ALLK – Allakos Inc. |
Financial data and stock pages provided by
Fintel.io